In this issue:
Leukaemia selection
Chimeric antigen receptor T-cells in ALL
Bosutinib vs. imatinib safety in newly diagnosed chronic-phase CML
Obinutuzumab in relapsed/ refractory CLL
Long-term results of first salvage with RFC in CLL
Lymphoma selection
GDP vs. DHAP pre-SCT for relapsed/refractory aggressive lymphomas
Impact of induction and SCT on DHL outcomes
Relevance of bone-marrow biopsy in PET-CT-staged treatment-naive HL
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity in DLBCL
RCD in monoclonal Ig depositrelated glomerulopathy and indolent NHL
Routine post-therapy surveillance imaging in DLBCL
Please login below to download this issue (PDF)